IL6 and bacterial urinary tract infection: These findings suggest that pharmacological modulation of systemic IL-6 may mitigate delirium-like functional and structural phenotypes after UTI and serve as pre-clinical justification for clinical investigations using IL-6 inhibition to treat UTI-induced delirium.